Factors involved in rosuvastatin induction of insulin sensitization in rats fed a high fat diet

详细信息    查看全文

• 作者：N. de las Heras ; M. Valero-Mu帽oz ; S. Ballesteros ; A. G贸mez-Hern谩ndez ; B. Mart铆n-Fern谩ndez ; J. Blanco-Rivero ; V. Cachofeiro ; M. Benito ; G. Balfag贸n ; V. Lahera
• 关键词：Statin ; Insulin resistance ; Adipose tissue ; SIRT-1
• 刊名：Nutrition, Metabolism and Cardiovascular Diseases
• 出版年：November, 2013
• 年：2013
• 卷：23
• 期：11
• 页码：1107-1114
• 全文大小：779 K

文摘

Background and Aim

To investigate whether rosuvastatin can improve insulin sensitivity in overweight rats having a high fat diet (HFD). The potential mechanisms involved in this action were evaluated, including SIRT-1, other factors involved in glucose metabolism and stress signaling pathways.

Methods and Results

Male Wistar rats (n聽=聽30) were divided into three groups: (i) rats fed a standard diet (3.5% fat); (ii) rats fed a HFD (33.5% fat); and (iii) rats fed a HFD and treated with rosuvastatin (15聽mg/kg/day). Evolution: 7 weeks. HFD rats showed increased body, epididymal and lumbar adipose tissue weights. Plasma levels of cholesterol, triglycerides, VLDL, glucose and insulin and leptin/adiponectin ratio were higher in HFD rats, and rosuvastatin treatment reduced them. SIRT-1, p53, PGC-1伪, PPAR-纬 and GLUT-4 protein levels in white adipose tissue (WAT) were lower, and JNK was higher in HFD rats compared to controls. Rosuvastatin treatment normalized expression of these mediators. Endothelium-dependent relaxation was reduced in mesenteric rings from HFD rats compared to controls and rosuvastatin enhanced it in HFD rats.

Conclusion

Rosuvastatin treatment reduced insulin resistance without affecting body weight or WAT loss in HFD rats. Reduction of leptin and JNK, and enhancement of SIRT-1, p53, PGC-1伪, PPAR-纬 and GLUT-4 expression in WAT could contribute to insulin sensitization. Normalization of SIRT-1 expression in WAT could be considered a key novel mechanism that aids in explaining the beneficial effects of rosuvastatin on the amelioration of glucose metabolism and the arrangement of multiple signaling pathways participating in insulin resistance in overweight HFD rats.